American Century Companies’s Lyell Immunopharma LYEL Stock Holding History

American Century Companies's LYEL Position: Q2 2026 in Review

American Century Companies increased its Lyell Immunopharma (LYEL) stake by 54% in Q2 2026, buying an estimated $155K and bringing the position to 24,540 shares worth $345K. The position accounts for ﹤0.01% of the portfolio, ranked #2678.

American Century Companies first reported a position in LYEL in Q3 2022 and has held it in 10 quarters since. The position peaked at $528K in Q1 2024. 87 funds tracked by Wall St. Rank hold LYEL as of Q2 2026.

• American Century Companies held 24,540 shares of Lyell Immunopharma worth $345K as of Q2 2026.
• American Century Companies bought 8,569 Lyell Immunopharma shares in Q2 2026, an estimated $155K.
• Lyell Immunopharma made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2678 holding.
• American Century Companies first reported a position in Lyell Immunopharma in Q3 2022 and has held it in 10 quarters since.
• American Century Companies's Lyell Immunopharma position peaked at $528K in Q1 2024.
• 87 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.